Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring

Not Applicable

Active, not recruiting

• Conditions: Dietary Monitoring

• Registration Number: NCT06919471
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

To learn if a method of abbreviated food tracking (called MySnackTracker) is a reasonable alternative to traditional full-intake food tracking and to compare the adherence to and acceptability of each method.

Detailed Description

Primary Objectives The goal of the study is to compare the adherence and acceptability of tracking only high-energy low-nutrient value foods to standard full intake monitoring of diet. We predict that use of the high-energy, low-nutrient-density food tracking app will result in greater adherence to self-monitoring and greater satisfaction with monitoring in comparison to the full intake tracking.

Secondary Objectives Assess the efficacy of the snack tracking app versus standard self-monitoring as measured by changes in the following measures between baseline and follow up; percentage weight change, weight loss self-efficacy scores, food logging self-efficacy scores, GODIN leisure time activity questionnaire scores, Vioscreen tool responses for stages of change for fats and fruit/vegetable intake, daily fruit consumption, daily vegetable consumption, servings of sweets per day, Healthy Eating Index (HEI) Score for calories from solid fats, alcohols, added sugars, HEI empty calories, total drinks of alcohol per day, calories from alcoholic beverages per day, added sugars by available carbohydrates, added sugars by total grams of sugar, calorie intake, carbohydrate intake, fat intake, saturated fatty acid intake, and total sugar intake.

Study Timeline

• Study First Submitted: 2025-04-02
• Study First Submitted QC: 2025-04-02
• Study Start: 2025-04-08
• Study First Posted: 2025-04-09
• Status Verified: 2025-05
• Last Update Submitted: 2025-05-05
• Last Update Posted: 2025-05-08
• Primary Completion: 2028-05-01
• Study Completion: 2030-05-01

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Safety and adverse events	Through study completion; an average of 1 year	Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events

Trial Locations

Locations (1)

MD Anderson Cancer Center; 🇺🇸 Houston, Texas, United States